Post Results [Q1 2017-2018 April To June 2017] Q&A; Session Through Teleconference Has Been Scheduled On August 11, 2017 At 4:30 P.M.
As per the attached letter.01-08-2017
01-08-2017
Zydus Cadila gets USFDA approval for colitis drug; margins get a boost
Currently, it sells the authorised generic version of Asacol HD in the US25-07-2017
Press Release
'Zydus receives final approval from USFDA for Mesalamine Delayed Release Tablets, 800 mg'.25-07-2017
Updates
Please find attached herewith the copies of the advertisement of Notice of Twenty Second Annual General Meeting, E-voting and Book Closure information published in the English and Gujarati editions of Financial Express on July 21, 2017 for the perusal of your good office.21-07-2017
Zydus launches ulcer drug in US; gets FDA nod for haemophilia drug
Cadila Healthcare Ltd (Zydus Cadila), on Wednesday, said it has commercially launched the Mesalamine delayed release tablet USP, for the treatment of mild to moderate ulcerative colitis, in the US...19-07-2017
Real innovation will now happen in East and move to West'
Zydus Cadila's newly appointed chief sees bio-similars, biologics and vaccines critical for revenue generation, growth18-07-2017
Cut-Off Date For Twenty Second Annual General Meeting Scheduled To Be Held On Friday, August 11, 2017 At 1.00 P.M.
The Cut-Off Date for determining the eligibility of the members entitled to vote by electronic means and at the venue of Twenty Second Annual General Meeting scheduled to be held on Friday, August 11, 2017 at 1.00 p.m. The members holding shares as on the cut-off date will be entitled to exercise their voting rights electronically or at the venue of the Annual General Meeting.18-07-2017
Intimation Of Meeting Of Board Of Directors And Closure Of Trading Windows.
In compliance with the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosures Requirements) Regulation 2015, we hereby inform that the meeting of the Board of Directors of the Company will be held on Friday, the August 11, 2017 to consider, inter alia, approve the unaudited financial results for the quarter ended on June 30, 2017....15-07-2017